Menu
GeneBe

12-120199133-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001002.4(RPLP0):c.303G>A(p.Met101Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

RPLP0
NM_001002.4 missense

Scores

1
3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.83
Variant links:
Genes affected
RPLP0 (HGNC:10371): (ribosomal protein lateral stalk subunit P0) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein, which is the functional equivalent of the E. coli L10 ribosomal protein, belongs to the L10P family of ribosomal proteins. It is a neutral phosphoprotein with a C-terminal end that is nearly identical to the C-terminal ends of the acidic ribosomal phosphoproteins P1 and P2. The P0 protein can interact with P1 and P2 to form a pentameric complex consisting of P1 and P2 dimers, and a P0 monomer. The protein is located in the cytoplasm. Transcript variants derived from alternative splicing exist; they encode the same protein. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29164642).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RPLP0NM_001002.4 linkuse as main transcriptc.303G>A p.Met101Ile missense_variant 4/8 ENST00000392514.9
RPLP0NM_053275.4 linkuse as main transcriptc.303G>A p.Met101Ile missense_variant 4/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RPLP0ENST00000392514.9 linkuse as main transcriptc.303G>A p.Met101Ile missense_variant 4/81 NM_001002.4 P1P05388-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461438
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727054
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 26, 2022The c.303G>A (p.M101I) alteration is located in exon 4 (coding exon 3) of the RPLP0 gene. This alteration results from a G to A substitution at nucleotide position 303, causing the methionine (M) at amino acid position 101 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.020
T
BayesDel_noAF
Benign
-0.27
Cadd
Uncertain
24
Dann
Uncertain
0.98
DEOGEN2
Benign
0.11
T;T;.;T;T;T;T;.;.;T;.
Eigen
Benign
-0.10
Eigen_PC
Benign
0.16
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.29
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.99
N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.19
Sift
Benign
0.23
T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.23
T;T;T;T;T;T;T;.;T;.;.
Polyphen
0.0010
B;B;.;.;B;.;.;.;.;.;.
Vest4
0.60
MutPred
0.46
Gain of catalytic residue at L102 (P = 0.0015);Gain of catalytic residue at L102 (P = 0.0015);Gain of catalytic residue at L102 (P = 0.0015);Gain of catalytic residue at L102 (P = 0.0015);Gain of catalytic residue at L102 (P = 0.0015);Gain of catalytic residue at L102 (P = 0.0015);.;Gain of catalytic residue at L102 (P = 0.0015);.;.;Gain of catalytic residue at L102 (P = 0.0015);
MVP
0.53
MPC
0.76
ClinPred
0.79
D
GERP RS
5.3
Varity_R
0.24
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-120636936; API